MannKind Corporation (MNKD) Bulls Bet On a Bigger Bounce

MannKind Corporation (MNKD) is one of several pharma stocks on the move

Digital Content Group

Mar 10, 2015 at 2:27 PM

MNKD

It's been an eventful day for pharmaceutical stocks, with a number of names making big moves -- including MannKind Corporation (NASDAQ:MNKD). At last check, the shares were up 3.2% at $5.51. Turning to the options pits, a number of traders are wagering on additional upside for the equity.

MNKD's most active option by a mile is the in-the-money May 5 call. All signs point to buy-to-open activity, and based on the volume-weighted average price (VWAP) of $0.67, the speculators expect the stock will land above breakeven at $5.67 (strike plus VWAP) at the close on Friday, May 15 -- when the option expires.

Today's focus on calls represents a change of pace for MNKD. The equity's 50-day International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX) put/call volume ratio of 0.67 ranks in the 76th percentile of its annual range. Similarly, MNKD's Schaeffer's put/call open interest ratio (SOIR) of 0.84 outstrips 73% of all comparable readings from the last year.

One group that's likely unhappy with MannKind Corporation's (NASDAQ:MNKD) intraday gains is short sellers. Roughly one-third of the stock's float is dedicated to short interest, representing 9.3 times the equity's daily trading volume.

Follow @Schaeffers

Minimize Risk While Maximizing Profits

There is no options strategy like this one, which consistently minimizes risk while maintaining maximum profits. Perfect for traders looking for ways to control risk, reduce losses, and increase the likelihood of success when trading calls and puts. The Schaeffer’s team has over 41 years of options trading success targeting +100% gains on every trade. Rest assured your losses are effectively limited to your initial cost at the time of making your move! Don't waste another second... join us right now before the next trade is released!